1 completed, 1 enrolling by invitation. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Completed 1 |
Follow Ruthenium-106: new trials by email Literature Review of Ruthenium-106 trials Research Report on Ruthenium-106
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Melphalan Chemoreduction for Ocular Melanoma Melphalan Injection, Plaque brachytherapy - Uveal Melanoma | Phase 1 / Phase 2 | Enrolling by invitation | Hospital das Clínicas de Ribeirão Preto | 10 | 2021-05-01 | 2025-09-15 |
| Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma Carboplatin, Cryosurgery, Infrared Laser Therapy - Intraocular Retinoblastoma | Phase 3 | Completed | Children's Oncology Group | 28 | 2005-12-26 | 2023-03-13 |
Melanoma (1) · Uveal Melanoma (1)
Children's Oncology Group (1) · Hospital das Clínicas de Ribeirão Preto (1)
Brazil (1) · United States (1)
Debra L Friedman (1) · Rodrigo Jorge, MD, PhD (1)
U10CA098543 (1)